MedTrace Logo

Pain Multidisciplinar Intervention in Major Trauma Patients

NCT05355441 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 38

Last updated 2025-02-12

No results posted yet for this study

Summary

In Spain, major trauma continues to be the leading cause of death among young people. However, mortality rates represent only a relatively small part of the impact of trauma injuries on the health of the population. Pain and anxiety are two of the most poorly controlled factors that have a huge impact on a patient's quality of life.The type of therapy that has been shown to be most effective in treating post-traumatic pain is one that involves different specialists, given its multicausality, care should be multidisciplinary.

This investigation project consists in an observational study performed by a multidisciplinary team in our center. Major trauma patients with moderate, severe or incapacitating pain will be referred to consultations specialized in chronic pain and psychology. One year after the trauma, patients will be evaluated in terms of quality of life.

The aim of this study is to determinate the impact that multidisciplinary treatment of post-traumatic pain has on the perception of quality of life in severely injured patients.

Conditions

Interventions

DRUG

Paracetamol

Routine clinical practice treatments recommended by the medical team involved

DRUG

Ibuprofen 600 mg

Routine clinical practice treatments recommended by the medical team involved

DRUG

Tramadol

Routine clinical practice treatments recommended by the medical team involved

DRUG

Morphine

Routine clinical practice treatments recommended by the medical team involved

Sponsors & Collaborators

  • Corporacion Parc Tauli

    collaborator OTHER

  • Nuria Llorach-Perucho

    lead OTHER

Principal Investigators

  • Nuria Llorach-Perucho, MD · Corporacion Parc Tauli

  • Salvador Navarro-Soto, MD, PhD · Corporacion Parc Tauli

  • Heura Llaquet-Bayo, MD, PhD · Corporacion Parc Tauli

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-01
Primary Completion
2024-04-01
Completion
2024-11-01

Countries

  • Spain

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05355441 on ClinicalTrials.gov